Altamira Therapeutics Ltd.
CYTOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601936
No open-market purchases or sales by Altamira Therapeutics Ltd. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Altamira Therapeutics Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 17 | +17 |
| Shares | 0 | 669.6K | +669.6K |
| Value | $0 | $1.34M | +$1.34M |
New holders (17)
Institutions that held Altamira Therapeutics Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 399,148 | $803.0K | 0.18% |
| Renaissance Technologies LLC | 71,226 | $143.0K | 0.00% |
| Citadel Advisors LLC | 57,572 | $116.0K | 0.00% |
| Boothbay Fund Management, LLC | 40,273 | $81.0K | 0.00% |
| BlackRock Inc. | 32,592 | $65.0K | 0.00% |
| Geode Capital Management, LLC | 18,871 | $37.0K | 0.00% |
| Two Sigma Investments, LP | 16,019 | $32.0K | 0.00% |
| Morgan Stanley | 15,648 | $31.0K | 0.00% |
| Wells Fargo & Company | 8,435 | $17.0K | 0.00% |
| UBS Group AG | 3,923 | $8.00K | 0.00% |
| Advisor Group Holdings, Inc. | 1,936 | $4.00K | 0.00% |
| Group One Trading, L.P. | 1,559 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 893 | $2.00K | 0.00% |
| Cutler Group LP | 1,200 | $2.00K | 0.00% |
| Bank of America Corp | 1 | $0 | 0.00% |
| Stonebridge Capital Advisors LLC | 100 | $0 | 0.00% |
| Rockefeller Capital Management L.P. | 250 | $0 | 0.00% |
Sold out (0)
Institutions that held Altamira Therapeutics Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
None.